Over the past 12 months, 13 insiders at Wave Life Sciences Ltd. filed 50 open-market SEC Form 4 transactions on WVE: 6 purchases worth $82.6M and 44 sales worth $16.6M. Insiders have been net sellers over this period. The most recent filing was on Mar 30, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 26 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 971.1K | $6.50 | $6.3M |
| Mar 27, 26 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 2.50M | $6.43 | $16.0M |
| Mar 26, 26 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 4.95M | $6.38 | $30.0M |
| Feb 26, 26 | Chris FrancisSee Remarks | SELL | 17.9K | $15.09 | $270K |
| Feb 9, 26 | Paul BolnoPresident and CEO | SELL | 10.5K | $13.45 | $141K |
| Feb 9, 26 | Chris FrancisSee Remarks | SELL | 1.9K | $13.45 | $25K |
| Feb 9, 26 | Kyle MoranChief Financial Officer | SELL | 3.6K | $13.45 | $48K |
| Feb 9, 26 | Chandra VargeeseSee Remarks | SELL | 3.2K | $13.45 | $43K |
| Jan 2, 26 | Chris FrancisSee Remarks | SELL | 8.1K | $16.70 | $129K |
| Dec 11, 25 | Gsk PlcTenPercentOwner | BUY | 1.47M | $19.00 | $27.9M |
| Dec 9, 25 | Kyle MoranChief Financial Officer | SELL | 50.0K | $20.25 | $1.0M |
| Dec 8, 25 | Mark CorriganDirector | SELL | 9.6K | $14.07 | $126K |
| Dec 8, 25 | Chris FrancisSee Remarks | SELL | 122.3K | $16.00 | $1.7M |
| Dec 8, 25 | Christian O HenryDirector | SELL | 42.0K | $18.02 | $541K |
| Dec 8, 25 | Kyle MoranChief Financial Officer | SELL | 60.0K | $13.20 | $792K |
| Dec 8, 25 | Adrian RawcliffeDirector | SELL | 42.0K | $15.00 | $630K |
| Dec 8, 25 | Aik Na TanDirector | SELL | 25.0K | $15.00 | $375K |
| Dec 8, 25 | Gregory L. VerdineDirector | SELL | 12.0K | $14.05 | $157K |
| Dec 8, 25 | Heidi L WagnerDirector | SELL | 7.0K | $14.00 | $98K |
| Nov 13, 25 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 1.0K | $6.69 | $7K |
| Nov 13, 25 | Adrian RawcliffeDirector | SELL | 16.1K | $6.79 | $109K |
| Aug 22, 25 | Paul BolnoPresident and CEO | SELL | 217.4K | $10.10 | $2.2M |
| Aug 22, 25 | Gregory L. VerdineDirector | SELL | 10.0K | $10.00 | $100K |
| Aug 15, 25 | Aik Na TanDirector | SELL | 21.0K | $9.25 | $194K |
| Aug 13, 25 | Christian O HenryDirector | SELL | 9.7K | $8.81 | $85K |
| Aug 5, 25 | Ken TakanashiDirector | SELL | 4.9K | $8.75 | $43K |
| Aug 5, 25 | Aik Na TanDirector | SELL | 1.1K | $8.75 | $10K |
| Jun 13, 25 | Gregory L. VerdineDirector | SELL | 30.0K | $6.95 | $209K |
| Mar 20, 25 | Christian O HenryDirector | SELL | 10.5K | $9.77 | $103K |
| Mar 7, 25 | Paul BolnoPresident and CEO | SELL | 169.0K | $9.57 | $1.6M |
| Nov 25, 24 | Paul BolnoPresident and CEO | SELL | 50.0K | $15.00 | $750K |
| Nov 15, 24 | Paul BolnoPresident and CEO | SELL | 51.2K | $14.32 | $734K |
| Nov 8, 24 | Chris FrancisSee Remarks | SELL | 36.0K | $16.00 | $576K |
| Oct 16, 24 | Paul BolnoPresident and CEO | SELL | 90.5K | $15.00 | $1.4M |
| Oct 16, 24 | Chris FrancisSee Remarks | SELL | 79.7K | $14.00 | $1.1M |
| Sep 27, 24 | Gsk PlcTenPercentOwner | BUY | 2.79M | $8.00 | $22.3M |
| Sep 25, 24 | Kyle MoranChief Financial Officer | SELL | 17.1K | $9.00 | $154K |
| Aug 21, 24 | Paul BolnoPresident and CEO | SELL | 48.4K | $5.78 | $280K |
| Apr 3, 24 | Kyle MoranChief Financial Officer | SELL | 15.6K | $6.17 | $96K |
| Dec 11, 23 | Peter KolchinskyDirector,TenPercentOwner | BUY | 1.00M | $5.00 | $5.0M |
| Dec 11, 23 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 1.00M | $5.00 | $5.0M |
| Dec 7, 23 | Gsk PlcTenPercentOwner | BUY | 3.30M | $5.00 | $16.5M |
| Aug 23, 23 | Kyle MoranChief Financial Officer | SELL | 37.1K | $4.75 | $176K |
| Feb 16, 23 | Paul BolnoPresident and CEO | SELL | 29.4K | $4.04 | $119K |
| Feb 16, 23 | Chris FrancisSee Remarks | SELL | 10.3K | $4.03 | $41K |
| Feb 16, 23 | Kyle MoranChief Financial Officer | SELL | 9.7K | $4.04 | $39K |
| Feb 16, 23 | Chandra VargeeseSee Remarks | SELL | 10.2K | $4.03 | $41K |
| Jun 16, 22 | Ra Capital Healthcare Fund LpDirector,TenPercentOwner | BUY | 9.48M | $2.15 | $20.4M |
| May 5, 22 | Paul BolnoPresident and CEO | SELL | 33.5K | $1.72 | $58K |
| May 5, 22 | Chris FrancisSee Remarks | SELL | 10.9K | $1.72 | $19K |
Over the past 12 months, insiders at Wave Life Sciences Ltd. filed 6 open-market purchases worth $82.6M and 44 sales worth $16.6M on WVE, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 30, 26.
The largest recent open-market WVE insider purchase in our data was $30.0M by Ra Capital Management, L.p., Director,TenPercentOwner, filed on Mar 26, 26.
13 different insiders at Wave Life Sciences Ltd. filed open-market SEC Form 4 transactions on WVE over the last 12 months.
InsiderTape plots every WVE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Wave Life Sciences Ltd. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →